作为对抗抗克拉里素耐药性Mycobacterium的宿主导疗法的N-Acetylcysteine
Shuqi Yang1,2, Ying Zhang1,2, Jinchuan Xu1,3
1Shanghai Public Health Clinical Center, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
Pathogens (Basel, Switzerland)
|May 7, 2025
概括
N-乙半氨酸 (NAC) 显示出作为一种宿主导疗法,用于治疗抗克拉里素的Mycobacterium疹感染. 通过增强抗氧化作用和调节炎症途径,NAC免疫疗法可降低细菌负载.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗克拉里思素的Mycobacterium疹感染带来了重大治疗挑战.
- 对于非结核性菌根菌的传统疗法可以破坏宿主免疫平衡.
- 宿主导免疫疗法为M. abscessus感染提供了一个潜在的替代方案.
研究的目的:
- 为了评估N-乙半氨酸 (NAC) 对抗抗克拉里素耐药的M. abscessus的治疗疗效.
- 调查NAC保护作用的潜在免疫机制.
- 探索NAC作为对抗药物耐药M.的宿主导疗法.
主要方法:
- 查一种抗克拉里素的M.的临床隔离物.
- 在体外 (THP-1细胞) 和体内 (小鼠模型) 评估NAC的治疗效果.
- RNA测序和西斑用于分析免疫反应;使用抑制剂和激动剂进行途径分析.
主要成果:
- 在细胞和小鼠模型中,NAC免疫疗法显著降低了细菌负载.
- NAC治疗增强了抗氧化作用和降低了ASK1-MKK3/6-p38 MAPK炎症通路的调节.
- p38 MAPK通路的抑制模仿了NAC的保护作用,而激动作用减弱了它们,证实了通路的关键作用.
结论:
- 在抗药性Mycobacterium abscessus的治疗中,N-乙半氨酸具有显著的治疗潜力.
- 通过调节氧化应激和特定的炎症信号通路,NAC作为宿主导疗法起作用.
- 纳克代表了一种有前途的药物,用于对抗具有挑战性的克拉里素耐药性M.瘤感染.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
275
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
275
Anticholinesterase Agents: Poisoning and Treatment
751
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
751
Peptic Ulcer Disease IV: Management
51
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
51
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
99
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
99
Myasthenia Gravis: Overview and Treatment
996
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
996
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
109
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
109


